The maker of popular drugs, Wegovy and Ozempic, plans to ship its products to and from the U.S. via air freight, the report ...

State workers’ access to weight loss drugs has put House Speaker Tim Moore at odds with State Treasurer Dale Folwell, who ran ...

The longshoreman’s strike shutting down ports along the East and Gulf Coasts may cause a significant shortage of widely used ...

The startup will be headed by CEO Ron Renaud, who previously led Cerevel Therapeutics — a developer of drugs for neurological conditions — and oversaw its acquisition by AbbVie in an $8.7 billion deal ...

Eli Lilly (NYSE:LLY) is reportedly looking to study its popular weight-loss drug Zepbound in people who aren't considered ...

Click here to view the custom infographic of the Annovis Bio editorial. Clickhere  to view the custom infographic of theAnnovis Bioeditorial. Buntanetap vs. AD Annovis Bio Inc. (NYSE: ANVS)  is at the ...

A series of state and federal lawsuits challenging coverage exclusions for obesity drugs and procedures are testing the ...

Market: Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Active Compound Used, Type of GLP-1 ...

"Pharmacy middlemen" are to blame for the high cost of drugs like Wegovy and Ozempic, according to Novo Nordisk's CEO. Is ...